In this study, researchers aimed to determine whether ctDNA is detectable in other bodily fluids besides blood, and to characterize any ctDNA they were able to detect.

Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

New report highlights accelerating cyber incidents, emerging AI governance risks, and the growing importance of ...

Scientists have shown that a non-invasive sound stimulation of the brain at a specific frequency can clear toxic proteins ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

Published in Brain Stimulation, the Baycrest/Rotman team used fMRI to show rapid CSF dynamics changes after brief pulsed PBM ...

A teenager from Beijing, China, became the youngest ever person to be diagnosed with Alzheimer's in 2022 and MRI scans show ...

A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

Singaporean scientists have identified a possible early marker of Alzheimer's disease associated with disruption of the ...